covid-19 death information patient

Authors retract controversial hydroxychloroquine study

Reading now: 574
www.cidrap.umn.edu

Three of the authors of a study published last month in The Lancet on the use of the antimalaria drugs hydroxychloroquine and chloroquine to treat COVID-19 patients today requested the study be retracted because they can't vouch for the underlying data.The retraction is the latest step in a drama that's been unfolding since the study was originally published on May 22.

The observational study involving more than 96,000 patients found that hydroxychloroquine and chloroquine provided no benefit to COVID-19 patients and was associated with a higher risk of death and serious heart rhythm complications.

But critics almost immediately began questioning the validity of the data used in the study.An open letter sent last week to the editor of The

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA